Reaction Details | |||
---|---|---|---|
Report a problem with these data | |||
Target | Adenosine receptor A2a | ||
Ligand | BDBM561435 | ||
Substrate/Competitor | n/a | ||
Meas. Tech. | Adenosine A2A Receptor Cyclic AMP GS Assay | ||
Ki | <10±n/a nM | ||
Citation | Huang, T; Wang, X Pyrazolopyridines and triazolopyridines as A2A / A2B inhibitors US Patent US11390624 Publication Date 7/19/2022 | ||
More Info.: | Get all data from this article, Assay Method | ||
Adenosine receptor A2a | |||
Name: | Adenosine receptor A2a | ||
Synonyms: | A2A adenosine receptor (hA2A) | AA2AR_HUMAN | ADENOSINE A2 | ADENOSINE A2a | ADORA2 | ADORA2A | Adenosine A2A receptor (A2AAR) | ||
Type: | G Protein-Coupled Receptor (GPCR) | ||
Mol. Mass.: | 44716.46 | ||
Organism: | Homo sapiens (Human) | ||
Description: | P29274 | ||
Residue: | 412 | ||
Sequence: |
| ||
BDBM561435 | |||
n/a | |||
Name | BDBM561435 | ||
Synonyms: | 3-(4-amino-7-(4-methyloxazol-5-yl)-2-(2-(pyridin-2-yl)ethyl)-2H-[1,2,3]triazolo[4,5-c]pyridin-6-yl)-2-fluorobenzonitrile | US11390624, Example 49 | ||
Type | Small organic molecule | ||
Emp. Form. | C23H17FN8O | ||
Mol. Mass. | 440.4325 | ||
SMILES | Cc1ncoc1-c1c(nc(N)c2nn(CCc3ccccn3)nc12)-c1cccc(C#N)c1F |(1.47,2.32,;.01,2.8,;-.47,4.26,;-2.01,4.26,;-2.48,2.8,;-1.24,1.9,;-1.24,.36,;-2.57,-.41,;-2.57,-1.95,;-1.24,-2.72,;-1.24,-4.26,;.1,-1.95,;1.56,-2.43,;2.47,-1.18,;4.01,-1.18,;4.78,.15,;6.26,.55,;7.35,-.54,;8.84,-.14,;9.24,1.34,;8.15,2.43,;6.66,2.03,;1.56,.06,;.1,-.41,;-3.9,.36,;-3.9,1.9,;-5.24,2.67,;-6.57,1.9,;-6.57,.36,;-7.91,-.41,;-9.24,-1.18,;-5.24,-.41,;-5.24,-1.95,)| | ||
Structure |